Chris Shumway's Insider Trades & SAST Disclosures

Chris Shumway's most recent trade in Finch Therapeutics Group Inc was a trade of 10,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 8, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Finch Therapeutics Group Inc
Chris Shumway Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 10,000 10,000 - - Stock Option (right to buy)
Finch Therapeutics Group Inc
Chris Shumway Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2022 44,843 44,843 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades